Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minimizing donor exposure in hemotherapy

J P AuBuchon1

  • 1Blood Bank and Transfusion Service, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756.

Archives of Pathology & Laboratory Medicine
|April 1, 1994
PubMed
Summary

Minimizing risks in blood transfusions involves careful consideration of alternatives to allogeneic transfusion. Tailoring hemotherapy and transfusing only when clinically justified maximizes patient benefit while reducing potential complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter on Bacterial contamination in platelet concentrates.

Vox sanguinis·2014
Same author

A comparison of health care and blood supply system structures.

Vox sanguinis·2010
Same author

Research and development.

Vox sanguinis·2010
Same author

Inventory management.

Vox sanguinis·2010
Same author

Investigating the possibility of drug-dependent platelet antibodies.

Immunohematology·2010
Same author

Reducing the variation in performance of antibody titrations.

Archives of pathology & laboratory medicine·2008

Area of Science:

  • Medicine
  • Hematology
  • Transfusion Medicine

Background:

  • Blood transfusion, while a critical medical therapy, carries inherent risks and complications.
  • Allogeneic transfusion, using blood from volunteer donors, remains the predominant method.
  • Patient-specific hemotherapy requires careful consideration of risks versus benefits.

Purpose of the Study:

  • To explore strategies for minimizing risks associated with blood transfusions.
  • To highlight alternatives to standard allogeneic transfusion.
  • To emphasize tailoring hemotherapy to individual patient needs.

Main Methods:

  • Review of current transfusion practices and available alternatives.
  • Discussion of pharmacologic interventions to reduce transfusion risks.
  • Exploration of autologous blood strategies.

Main Results:

  • Numerous options exist to tailor hemotherapy, reducing risks and maximizing benefits.
  • Minimizing allogeneic exposure is achievable through various interventions.
  • Judicious transfusion, based on clear clinical benefit, is paramount.

Conclusions:

  • Patient-centered hemotherapy can significantly reduce transfusion-related risks.
  • Pharmacologic agents and autologous blood options offer valuable alternatives.
  • Optimizing transfusion strategies enhances patient safety and outcomes.

Related Experiment Videos